Valuation: NIOX Group Plc

Market Cap 268M 354M 320M 296M 505M 33.3B 520M 3.55B 1.41B 17.8B 1.33B 1.3B 56.67B P/E 2026 *
30.6x
P/E 2027 * 21.3x
Enterprise Value 240M 318M 287M 265M 453M 29.86B 466M 3.18B 1.26B 15.96B 1.19B 1.17B 50.81B EV / Sales 2026 *
4.75x
EV / Sales 2027 * 4.31x
Free-Float
78.35%
Yield 2026 *
2.9%
Yield 2027 * 3.27%
1 day+0.31%
1 week+2.24%
Current month-5.33%
1 month-7.25%
6 months+1.59%
Current year-3.61%
1 week 61.2
Extreme 61.2
66
1 month 60.89
Extreme 60.8941
80
Current year 53.84
Extreme 53.84
80
1 year 53.84
Extreme 53.84
80
3 years 53.4
Extreme 53.4
80
5 years 29
Extreme 29
80
10 years 12.5
Extreme 12.5
115.61
Manager TitleAgeSince
Chief Executive Officer - 16/01/2025
Director of Finance/CFO - 14/05/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 58 08/02/2018
Director/Board Member - 02/09/2019
Chairman 73 05/12/2019
Date Insider Type Main position Quantity % Market Cap. Importance
29/5/26 Buy

Chief Financial Officer

34,127 0.0081%
29/5/26 Sell

Chief Financial Officer

-33,916 0.0081%
28/5/26 Sell

Chief Financial Officer

-34,219 0.0081%
Change 5-day change 1-year change 3-year change Capi.($)
+0.63%+2.24%-9.86%+3.23% 356M
+0.96%+6.47%+42.76%+137.14% 1,280B
+2.00%+4.84%+46.87%+93.40% 675B
+0.73%+3.26%+27.62%+114.69% 521B
+1.14%+3.78%+39.98%+70.26% 386B
+1.32%+1.42%+62.96%+45.44% 363B
+1.11%+0.07%+28.19%+58.61% 301B
+0.24%-0.80%+3.05%+35.93% 286B
+0.84%+2.51%+40.31%+76.92% 253B
+0.70%+1.80%+38.23%+127.65% 211B
Average +0.93%-0.53%+32.01%+76.33% 428B
Weighted average by Cap. +1.08%+0.20%+38.97%+97.34%

Financials

2026 *2027 *
Net sales 50.48M 66.81M 60.41M 55.76M 95.25M 6.28B 98.1M 669M 266M 3.36B 251M 245M 10.69B 54.46M 72.07M 65.18M 60.16M 103M 6.78B 106M 722M 287M 3.62B 270M 265M 11.53B
Net income 9.25M 12.24M 11.07M 10.22M 17.46M 1.15B 17.98M 123M 48.75M 615M 45.95M 44.97M 1.96B 12.15M 16.07M 14.54M 13.42M 22.92M 1.51B 23.61M 161M 64M 808M 60.33M 59.04M 2.57B
Net Debt -27.71M -36.67M -33.16M -30.61M -52.29M -3.45B -53.86M -367M -146M -1.84B -138M -135M -5.87B -33.07M -43.77M -39.58M -36.54M -62.4M -4.11B -64.28M -439M -174M -2.2B -164M -161M -7B
Projected Income Statement - Annual - NIOX Group Plc
Logo NIOX Group Plc
NIOX Group plc is a United Kingdom-based diagnostics and management company. The Company is engaged in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNO), a precise biomarker for asthma. The Company's NIOX VERO is also the device of choice by clinical research organizations for respiratory studies. The device is used by healthcare professionals to improve asthma care, which assists diagnosis, determining responsiveness to inhaled corticosteroids, tailoring inhaled steroid use, monitoring treatment compliance, and reducing the likelihood of exacerbations in at-risk patients compared to traditional monitoring. The Company provides products and services via its direct sales organization and extensive distributor network in over 50 countries.
Employees
97
Date Price Change Volume
13/11/26 GBX 64.00 +0.63% 306,060
11/11/26 GBX 63.60 -1.24% 189,363
10/11/26 GBX 64.40 0.00% 194,476
09/11/26 GBX 64.40 +0.63% 3,468,392
06/11/26 GBX 64.00 +2.24% 1,197,890
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - NIOX Group Plc
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
0.6360GBP
Average target price
0.8240GBP
Spread / Average Target
+29.56%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - NIOX Group Plc